TP53 and cancer: It has been found that malignant tumors characterized by p53 mutations may share a common propagation mechanism with neurodegenerative diseases [9–12], and p53 can aggregate into structures such as oligomers or amyloid fibrils, which in turn can affect its normal suppressor function [13–15].